Literature DB >> 12841343

Decreased activity of lecithin:cholesterol acyltransferase and hepatic lipase in chronic hypothyroid rats: implications for reverse cholesterol transport.

Martha Franco1, Graciela Castro, Luis Romero, Juan Carlos Regalado, Aida Medina, Claudia Huesca-Gómez, Serafín Ramírez, Luis F Montaño, Carlos Posadas-Romero, Oscar Pérez-Méndez.   

Abstract

Chronic hypothyroidism is frequently associated with atherosclerosis due to increased cholesterol plasma levels; nevertheless, the contribution of impaired reverse cholesterol transport (RCT) in this process has not been completely elucidated. The aim of this study was to evaluate the effect of thyroidectomy (Htx) upon the main stages of RCT in rats. Plasma lipid alterations induced by thyroidectomy showed a slight, but significant, reduction of total plasma triglycerides, a 300% increase of LDL-cholesterol and a 25% decrease in HDL-cholesterol compared to control rats. We evaluated the first stage of RCT determining 3H-cholesterol efflux in Fu5AH cells. The capacity of HDL obtained from Htx rats to promote cholesterol efflux was similar to that of controls. Lecithin:cholesterol acyltransferase (LCAT) activity, the second stage and the driving force of RCT was 30% lower in Htx animals compared to controls, as determined by reconstituted HDL used as an external substrate. Lipoproteins are remodeled by hepatic lipase; the mean activity of this enzyme in postheparin plasma of Htx animals was reduced by 30% compared to controls, thus suggesting an impaired HDL remodeling by this enzyme in the hypothyroid status. In contrast, lipoprotein lipase activity in the Htx group was unchanged. In summary, this study demonstrates that chronic hypothyroidism in the rat induced an impaired RCT mainly at the cholesterol esterification, and HDL remodeling mediated by hepatic lipase. The latter probably results in an abnormal HDL structure, i.e. phospholipid enrichment, which contributes to decrease HDL-apo AI fractional catabolic rates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12841343

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  Identification of functional positive and negative thyroid hormone-responsive elements in the rat apolipoprotein AI promoter.

Authors:  A H Taylor; P Wishart; D E Lawless; J Raymond; N C Wong
Journal:  Biochemistry       Date:  1996-06-25       Impact factor: 3.162

2.  Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein.

Authors:  G R Castro; C J Fielding
Journal:  Biochemistry       Date:  1988-01-12       Impact factor: 3.162

3.  Adenosine regulates renal nitric oxide production in hypothyroid rats.

Authors:  M Franco; E Tapia; F Martínez; M E Davila; J I Grimaldo; K Medina; J Herrera-Acosta
Journal:  J Am Soc Nephrol       Date:  1999-08       Impact factor: 10.121

4.  The activity of cholesteryl ester transfer protein is decreased in hypothyroidism: a possible contribution to alterations in high-density lipoproteins.

Authors:  R P Dullaart; K Hoogenberg; J E Groener; L D Dikkeschei; D W Erkelens; H Doorenbos
Journal:  Eur J Clin Invest       Date:  1990-12       Impact factor: 4.686

5.  Triiodothyronine increases rat apolipoprotein A-I synthesis and alters high-density lipoprotein composition in vivo.

Authors:  J J Apostolopoulos; J F Marshall; G J Howlett
Journal:  Eur J Biochem       Date:  1990-11-26

6.  Serum lipids and apolipoproteins A-I, A-II and B in primary hypothyroidism before and during treatment.

Authors:  E Muls; M Rosseneu; V Blaton; E Lesaffre; G Lamberigts; P de Moor
Journal:  Eur J Clin Invest       Date:  1984-02       Impact factor: 4.686

7.  Dyslipoproteinaemia in hypothyroidism of pituitary origin: effects of L-thyroxine substitution on lipoprotein lipase, hepatic lipase, and on plasma lipoproteins.

Authors:  S Valdemarsson; P Hedner; P Nilsson-Ehle
Journal:  Acta Endocrinol (Copenh)       Date:  1983-06

8.  Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins.

Authors:  F Pazos; J J Alvarez; J Rubiés-Prat; C Varela; M A Lasunción
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

9.  Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity.

Authors:  C H Chen; J J Albers
Journal:  J Lipid Res       Date:  1982-07       Impact factor: 5.922

Review 10.  Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies.

Authors:  A R Tall
Journal:  J Intern Med       Date:  1995-01       Impact factor: 8.989

View more
  7 in total

Review 1.  A novel model of cholesterol efflux from lipid-loaded cells.

Authors:  Di-xian Luo; De-liang Cao; Yan Xiong; Xu-hong Peng; Duan-fang Liao
Journal:  Acta Pharmacol Sin       Date:  2010-09-13       Impact factor: 6.150

2.  Perturbation of lipids and glucose metabolism associated with previous 2,4-D exposure: a cross-sectional study of NHANES III data, 1988-1994.

Authors:  Dina M Schreinemachers
Journal:  Environ Health       Date:  2010-02-26       Impact factor: 5.984

3.  Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis.

Authors:  Alla Mitrofanova; Judith Molina; Javier Varona Santos; Johanna Guzman; Ximena A Morales; G Michelle Ducasa; Jonathan Bryn; Alexis Sloan; Ion Volosenco; Jin-Ju Kim; Mengyuan Ge; Shamroop K Mallela; Matthias Kretzler; Sean Eddy; Sebastian Martini; Patricia Wahl; Santiago Pastori; Armando J Mendez; George W Burke; Sandra Merscher; Alessia Fornoni
Journal:  Kidney Int       Date:  2018-10-06       Impact factor: 10.612

4.  Pleiotropic effects of thyroid hormones: learning from hypothyroidism.

Authors:  Martha Franco; Edmundo Chávez; Oscar Pérez-Méndez
Journal:  J Thyroid Res       Date:  2011-06-27

Review 5.  Hashimoto Thyroiditis and Dyslipidemia in Childhood: A Review.

Authors:  Rade Vukovic; Aleksandra Zeljkovic; Biljana Bufan; Vesna Spasojevic-Kalimanovska; Tatjana Milenkovic; Jelena Vekic
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-10       Impact factor: 5.555

6.  Serum Lipidome Signatures of Dogs with Different Endocrinopathies Associated with Hyperlipidemia.

Authors:  Nadja S Sieber-Ruckstuhl; Wai Kin Tham; Franziska Baumgartner; Jeremy John Selva; Markus R Wenk; Bo Burla; Felicitas S Boretti
Journal:  Metabolites       Date:  2022-03-30

7.  HDL Cholesterol Efflux Capacity is Impaired in Severe Short-Term Hypothyroidism Despite Increased HDL Cholesterol.

Authors:  Trynke van der Boom; Congzhuo Jia; Joop D Lefrandt; Margery A Connelly; Thera P Links; Uwe J F Tietge; Robin P F Dullaart
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.